Wearing Compression Tights on the Thigh during Prolonged Running Attenuated Exercise-Induced Increase in Muscle Damage Marker in Blood

Compression garments (CGs) provide a means of applying mechanical pressure at the body surface, thereby compressing and perhaps stabilizing/supporting underlying tissue. The body segments compressed and applied pressures ostensibly reflect the purpose of the garment, which is to mitigate exercise-induced discomfort or aid aspects of current or subsequent exercise performance. Potential benefits may be mediated via physical, physiological or psychological effects, although underlying mechanisms are typically not well elucidated. Despite widespread acceptance of CGs by competitive and recreational athletes, convincing scientific evidence supporting ergogenic effects remains somewhat elusive. The literature is fragmented due to great heterogeneity among studies, with variability including the type, duration and intensity of exercise, the measures used as indicators of exercise or recovery performance/physiological function, training status of participants, when the garments were worn and for what duration, the type of garment/body area covered and the applied pressures. Little is known about the adequacy of current sizing systems, pressure variability within and among individuals, maintenance of applied pressures during one wear session or over the life of the garment and, perhaps most importantly, whether any of these actually influence potential compression-associated benefits. During exercise, relatively few ergogenic effects have been demonstrated when wearing CGs. While CGs appear to aid aspects of jump performance in some situations, only limited data are available to indicate positive effects on performance for other forms of exercise. There is some indication for physical and physiological effects, including attenuation of muscle oscillation, improved joint awareness, perfusion augmentation and altered oxygen usage at sub-maximal intensities, but such findings are relatively isolated. Sub-maximal (at matched work loads) and maximal heart rate appears unaffected by CGs. Positive influences on perceptual responses during exercise are limited. During recovery, CGs have had mixed effects on recovery kinetics or subsequent performance. Various power and torque measurements have, on occasions, benefitted from the use of CGs in recovery, but subsequent sprint and agility performance appears no better. Results are inconsistent for post-exercise swelling of limb segments and for clearance of myocellular proteins and metabolites, while effects on plasma concentrations are difficult to interpret. However, there is some evidence for local blood flow augmentation with compression. Ratings of post-exercise muscle soreness are commonly more favourable when CGs are worn, although this is not always so. In general, the effects of CGs on indicators of recovery performance remain inconclusive. More work is needed to form a consensus or mechanistically-insightful interpretation of any demonstrated effects of CGs during exercise, recovery or - perhaps most importantly - fitness development. Limited practical recommendations for athletes can be drawn from the literature at present, although this review may help focus future research towards a position where such recommendations can be made.

The influence of carbohydrate (1 l/h of a 6% carbohydrate beverage), gender, and age on pro- and anti-inflammatory plasma cytokine and hormone changes was studied in 98 runners for 1.5 h after two competitive marathon races. The marathoner runners were randomly assigned to carbohydrate (C, n = 48) and placebo (P, n = 50) groups, with beverages administered during the races in a double-blind fashion using color codes. Plasma glucose was higher and cortisol was lower in the C than in the P group after the race (P or =50 yr of age and the 75 subjects <50 yr of age. The pattern of change in IL-10, IL-1ra, and IL-8, but not IL-6, differed significantly between the C and the P group, with higher postrace values measured for IL-10 (109% higher) and IL-1ra (212%) in the P group and for IL-8 (42%) in the C group. In conclusion, plasma levels of IL-10, IL-1ra, IL-6, and IL-8 rose strongly in runners after a competitive marathon, and this was not influenced by age or gender. Carbohydrate ingestion, however, had a major effect in attenuating increases in cortisol and two anti-inflammatory cytokines, IL-10 and IL-1ra.

We investigated the effects of an Ironman triathlon race on markers of muscle damage, inflammation and heat shock protein 70 (HSP70). Nine well-trained male triathletes (mean +/- SD age 34 +/- 5 years; VO(2peak) 66.4 ml kg(-1) min(-1)) participated in the 2004 Western Australia Ironman triathlon race (3.8 km swim, 180 km cycle, 42.2 km run). We assessed jump height, muscle strength and soreness, and collected venous blood samples 2 days before the race, within 30 min and 14-20 h after the race. Plasma samples were analysed for muscle proteins, acute phase proteins, cytokines, heat shock protein 70 (HSP70), and clinical biochemical variables related to dehydration, haemolysis, liver and renal functions. Muscular strength and jump height decreased significantly (P < 0.05) after the race, whereas muscle soreness and the plasma concentrations of muscle proteins increased. The cytokines interleukin (IL)-1 receptor antagonist, IL-6 and IL-10, and HSP70 increased markedly after the race, while IL-12p40 and granulocyte colony-stimulating factor (G-CSF) were also elevated. IL-4, IL-1beta and tumour necrosis factor-alpha did not change significantly, despite elevated C-reactive protein and serum amyloid protein A on the day after the race. Plasma creatinine, uric acid and total bilirubin concentrations and gamma-glutamyl transferase activity also changed after the race. In conclusion, despite evidence of muscle damage and an acute phase response after the race, the pro-inflammatory cytokine response was minimal and anti-inflammatory cytokines were induced. HSP70 is released into the circulation as a function of exercise duration.